SmarterDividends
REGN

Regeneron Pharmaceuticals (REGN) Dividend

Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology · quarterly payer

$918.75

Undervalued · +20% Add to Portfolio

As of Nov 5, 2026, Regeneron Pharmaceuticals (REGN) pays a quarterly dividend of $0.94 per share, or $3.76 a year, a 0.40% yield at its $918.75 share price. The next ex-dividend date is Nov 20, 2026, paid Dec 3, 2026.

Forward Yield

0.40%

Annual Dividend

$3.76

Payout Ratio

8%

5-Yr Growth

—

Ex-Date

Nov 20, 2026

Frequency

Quarterly

Key facts about REGN's dividend

Data as of · Source: SmarterDividends data

  • As of Nov 5, 2026, Regeneron Pharmaceuticals, Inc. (REGN) has a forward dividend yield of 0.40%, based on an annual dividend of $3.76 per share and a share price of $918.75.
  • REGN has never cut its regular dividend in the payment history SmarterDividends has on record.
  • REGN's next ex-dividend date is Nov 20, 2026, with payment on Dec 3, 2026. Shares must be owned before that date to receive the dividend.
  • As of Nov 5, 2026, REGN pays out 8% of its trailing 12-month earnings as dividends (its payout ratio).
  • As of Nov 5, 2026, REGN's 0.40% yield is 29% below its five-year average yield of 0.56%.
  • As of Nov 5, 2026, SmarterDividends' blended fair-value estimate for REGN is $1,104.25 per share, 20% above the $918.75 share price, so REGN screens as undervalued.
  • Regeneron Pharmaceuticals, Inc. (REGN) pays its dividend quarterly, 4 times a year.
  • Regeneron Pharmaceuticals, Inc. (REGN) has raised its regular dividend 1 time and cut it 0 times across the 7 payments on record since 2025. Its most recent change was a 6.8% increase to $0.940 per share, going ex-dividend on Feb 20, 2026.
Cite this page

SmarterDividends, "REGN Dividend: Yield, Safety Grade & Next Ex-Date," updated Nov 5, 2026, https://smarterdividends.com/stocks/REGN

Is REGN a good dividend stock?

Mixed

Regeneron Pharmaceuticals, Inc. (REGN) pays a quarterly dividend yielding 0.40% ($3.76/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Advantages

  • Never cut its dividend on record
  • Comfortable payout ratio (8%)
  • 46% total price return over 5 years

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
0.40%
Payout Ratio
8%
Annual Dividend
$3.76
5-Yr Avg Growth
—
Ex-Dividend Date
Nov 20, 2026
Years of Growth
0
Frequency
quarterly
Beta
0.10
Market Cap
$95.0B
P/E Ratio
20.3
5-Yr Total Return
46%
52-Week Range
$591.52 – $935.35
Dividend Safety
—
Ever Cut?
No

REGN dividend raises and cuts

Regeneron Pharmaceuticals, Inc. (REGN) has raised its regular dividend 1 time and cut it 0 times across the 7 payments on record since 2025. Its most recent change was a 6.8% increase to $0.940 per share, going ex-dividend on Feb 20, 2026.

Ex-dateChangeOld → newMove
Feb 20, 2026Raise$0.880 → $0.940+6.8%
REGN ex-dividend date & scheduleNext ex-date Nov 20, 2026 · full ex-dividend historyView →REGN dividend historyEvery payment, totals by year, raises and cutsView →REGN dividend calculator100 shares pay $376.00 a year, $94.00 each quarterCalculate →REGN total return calculatorWhat $10,000 became, with dividends reinvested or taken as cashSee →

Frequently Asked Questions

Is REGN a good dividend stock?

Mixed. Regeneron Pharmaceuticals, Inc. (REGN) pays a quarterly dividend yielding 0.40% ($3.76/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal.

Is REGN undervalued?

Based on a blend of discounted cash flow, a dividend-discount model and an earnings-multiple estimate, REGN's fair value is about $1,104.25 versus a $918.75 share price — so it looks undervalued (+20% vs. fair value).

What is REGN's fair value?

Our blended fair-value estimate for REGN is about $1,104.25 per share, roughly 20% above the current $918.75 price — combining a discounted cash flow, a dividend-discount model and an earnings multiple.

Is REGN a buy, hold, or sell?

We don't issue formal ratings, but on the data REGN screens as "mixed" and undervalued. Regeneron Pharmaceuticals, Inc. (REGN) pays a quarterly dividend yielding 0.40% ($3.76/yr), with 0 years of growth. The picture is mixed — the dividend pays, but safety or growth signals are weaker than ideal. This is research for your own analysis, not investment advice.

Does REGN pay a dividend?

Yes. Regeneron Pharmaceuticals, Inc. pays a quarterly dividend of about $3.76 per share annually, a forward yield of roughly 0.40%.

How much dividend does 100 shares of REGN pay?

At $3.76 per share a year, 100 shares of REGN pay $376.00 a year in dividends before tax, about $94.00 each quarter. Buying them costs about $91,875 at the Nov 5, 2026 price.

What is REGN's dividend yield?

As of Nov 5, 2026, REGN's forward dividend yield is 0.40%, based on a $3.76 annual dividend and a $918.75 share price.

What is REGN's dividend per share?

As of Nov 5, 2026, REGN pays $3.76 per share per year, distributed on a quarterly basis.

What is REGN's dividend payout ratio?

As of Nov 5, 2026, REGN's payout ratio is 8% of trailing 12-month earnings — a comfortable level that leaves room to keep raising the dividend.

How many years has REGN grown its dividend?

REGN does not currently have a long dividend-growth streak on record.

When is the next REGN ex-dividend date?

As of Nov 5, 2026, the next ex-dividend date on record for REGN is Nov 20, 2026.